Login / Signup

New Insights into the Relationship between Gut Microbiota and Radiotherapy for Cancer.

Zhipeng LiXiyang KeDan ZuoZhicheng WangFang FangBo Li
Published in: Nutrients (2022)
Cancer is the second most common cause of death among humans in the world, and the threat that it presents to human health is becoming more and more serious. The mechanisms of cancer development have not yet been fully elucidated, and new therapies are changing with each passing day. Evidence from the literature has validated the finding that the composition and modification of gut microbiota play an important role in the development of many different types of cancer. The results also demonstrate that there is a bidirectional interaction between the gut microbiota and radiotherapy treatments for cancer. In a nutshell, the modifications of the gut microbiota caused by radiotherapy have an effect on tumor radiosensitivity and, as a result, affect the efficacy of radiotherapy and show a certain radiation toxicity, which leads to numerous side effects. What is of new research significance is that the "gut-organ axis" formed by the gut microbiota may be one of the most interesting potential mechanisms, although the relevant research is still very limited. In this review, we combine new insights into the relationship between the gut microbiota, cancer, and radiotherapy. Based on our current comprehensive understanding of this relationship, we give an overview of the new cancer treatments based on the gut microbiota.
Keyphrases
  • papillary thyroid
  • squamous cell
  • early stage
  • radiation therapy
  • lymph node metastasis
  • radiation induced
  • systematic review
  • risk assessment
  • squamous cell carcinoma
  • childhood cancer
  • young adults